1. Market Research
  2. > Pharmaceutical Market Trends
Europe Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product ; Application ; End User ; and, Country

Europe Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product ; Application ; End User ; and, Country

  • August 2020
  • 159 pages
  • ID: 5974369
  • Format: PDF
  • The Insight Partners


Table of Contents

Search Inside

Europe pharmaceutical continuous manufacturing market is anticipated to reach US$ 799.50 million by 2027 from US$ 374.95 million in 2019. The market is projected to grow with a CAGR of 10.0% from 2019 to 2027.
The growth of the Europe pharmaceutical continuous manufacturing market is primarily attributed to the increasing shortage of medicines.However, high cost involved in drug manufacturing is likely to restrain the growth of the market in the coming years.

On the other hand, strategic activities by the manufacturers are expected to have a positive impact on the growth of the Europe pharmaceutical continuous manufacturing market in the coming years.
Continuous manufacturing in the pharmaceutical industry is a result of advancements in technology with respect to the production techniques.The batch manufacturing method was traditionally followed in the pharmaceutical industry.

However, the development in technology has accelerated mass production with improved quality, and it has addressed the many primary causes such as the recall of drugs and recalls. The pharmaceutical industry has recently begun to implement the continuous manufacturing process as an option to improve and sustain manufacturing operations.
More than 300 pharmaceutical continuous manufacturing companies are established in the regions such as Missouri, Columbia, Kansas, and Manhattan.
Shortage of essential medicines and drugs is the major drawback experienced by the global healthcare sector.This shortage is resulting into additional costs as well as risk to the patients’ health.

The patients in need of medicines are failing to receive appropriate doses due to unavailability of medicines.According to the WHO Drug Information 2016, shortages of essential medicines have been reported from low, middle, and high-income countries.

Medicine shortage poses risk for patient health as a result of non-treatment, under-treatment, and possible medication errors from attempts to substitute missing medicines.The Food and Drug Administration (FDA) states that the drug shortage occurs due to various reasons including quality problems, manufacturing inefficiency, and delays and discontinuations.

The drugs that often fall short in supply include sterile injectable and oncology/cancer treatments. The notice from manufacturers to the FDA regarding the impending or current shortages of drugs allows the FDA to work with the manufacturers over finding feasible solutions, one of which is usually ramping up the manufacturing of drugs through implementation of new and advanced systems such as continuous manufacturing.
According to a report published by The Economist Intelligence Unit Limited in 2017, the prevalence of medicine shortage has been increased in Europe.The three major factors that determine the drug shortage are manufacturing, economic, and regulatory causes.

Thus, in order to meet the rising demand for biologics and drugs, as well as to curb the lack of drug availability, pharmaceutical continuous manufacturing is a suitable solution that has to be implemented in the system.
Europe has been massively hit by the COVID-19 outbreak affecting many of its countries on a large scale.Italy, Germany, Spain, the UK, and France, are the major countries witnessing a rise in COVID-19 cases every day.

As per data published by public sources, till March 26, Europe had an estimated 250,000 infected patients in the region.Also, the process of lockdown is expected to have a severe impact on new product launches and distributions.

For instance, Comecer is headquartered in Italy with its factories in Italy and the Netherlands. Due to the lockdown and severe spread of COVID-19, the manufacturing process is strongly affected, which, in turn is hampering the growth of the continuous pharmaceutical manufacturing market.
In terms of product, the integrated systems segment accounted for the largest share of the Europe pharmaceutical continuous manufacturing market in 2019 and is estimated to mark the highest CAGR in the market during the forecast period, owing to the factors such as their easy availability and accessibility as well as higher adoption of these systems compared to the semi-continuous systems. Also, the convenience of use of upright freezers has led to its dominance during 2019 and is expected to witness similar trend over the coming years.
Centers For Disease Control And Prevention (CDC), Defense Research and Development Organization (DRDO), and Functional Genomic and Computational Assessment of Threats (Fun GCAT) are among the significant primary and secondary sources for pharmaceutical continuous manufacturing included in the report others.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Global Process Analytical Instrumentation Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

  • $ 4250
  • September 2021
  • 211 pages

The global process analytical instrumentation market is expected to witness a CAGR of 7.56% over the forecast period (2021-2026). In the market analyzed, the recent COVID-19 outbreak resulted in high demand. ...

  • World
  • North America
  • Pharmaceutical
  • Oil And Gas
  • Industry analysis
  • Drug Approval
  • Crude Oil Price

Citrate Markets in China $ 4000 July 2021


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on